Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
KT Healthcare is seeking an experienced Speech and Language Therapist to support a 35-year-old client with an acquired brain injury. The role involves a comprehensive assessment and developing intervention to optimize functional communication across daily life and vocational contexts.
The associate contract offers flexible hours to fit client needs and therapist availability, with paid travel time and mileage.
KT Healthcare is a family-run organisation providing assessment and therapeutic services across the Neurodevelopmental, Brain Injury and Complex Care sectors. Our team of clinicians work on a sub-contracting basis – they are highly specialist and deliver high-quality assessments, reports, and therapy sessions within a multidisciplinary team.
We’re looking for an experienced Speech and Language Therapist to support a 35-year-old client with an acquired brain injury.
The client continues to present with a cognitive-communication disorder and difficulties with social communication. The role will involve completing a comprehensive assessment to identify the nature and impact of these difficulties and developing appropriate intervention and practical strategies to optimise functional communication.
The assessment and subsequent intervention will focus on supporting the client across a range of everyday environments, including:
We’re looking for an SLT with experience in acquired brain injury, cognitive-communication disorders and social communication difficulties, ideally with experience supporting adults in vocational and community settings.
At KT Healthcare, we are committed to fostering excellence in clinical practice and supporting our team to deliver the highest standards of care.
This is an excellent opportunity for an experienced Speech and Language Therapist seeking a rewarding associate role where they can make a meaningful difference to an adult’s functional communication, independence and participation following acquired brain injury.
© 2026 Kirsop-Taylor Healthcare Ltd. All rights reserved.